Skip to main content
. 2020 Feb 12;10:93. doi: 10.3389/fonc.2020.00093

Figure 6.

Figure 6

Forest plots of the sensitivity and specificity of DCE-MRI for prediction of the pathological complete response (pCR) of breast cancer to neoadjuvant chemotherapy. I2 > 50% indicated substantial heterogeneity in the diagnostic parameters across studies.